TITLE

P. AERUGINOSA INFECTION

PUB. DATE
September 1994
SOURCE
Advocate;9/20/94, Issue 664, p25
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports on the findings of Mount Sinai School of Medicine researchers that Pseudomonas aeruginosa bacteremia is a significant opportunistic pathogen in patients with AIDS.
ACCESSION #
9664215

 

Related Articles

  • ECTHYMA GANGRENOSUM: A RARE CUTANEOUS MANIFESTATION OF A POTENTIALLY FATAL DISEASE. Solowski, Nancy L.; Agarwal, Anurag; Yao, Francisca Brunelle; Nagorsky, Matthew // Annals of Otology, Rhinology & Laryngology;Jun2004, Vol. 113 Issue 6, p462 

    Ecthyma gangrenosum is a cutaneous lesion frequently associated with Pseudomonas aeruginosa bacteremia, although it may develop in the absence of bacteremia and may originate from other bacterial and fungal organisms. Ecthyma gangrenosum most often occurs in patients with neutropenia and other...

  • IL-18 Act as a Costimulus for Production of Interferon Gamma During Stimulation by Pseudomonas aeruginosa Infection. Al-Jabouri, Raed; Saqban, Abdul-Kareem Salman; Hasson, Shaimaa Obaid; Abady, Noor R. // Journal of Pure & Applied Microbiology;Jun2019, Vol. 13 Issue 2, p891 

    Pseudomonas aeruginosa (P. aeruginosa) is the most important, resistant and dangerous organism in burn wound infections in human. Extracellular and virulence factors lead to tissue damage tissue damage during infection with P. aeruginosa. One important virulence factor including exotoxin A(ETA)...

  • Pseudomonas aeruginosa sepsis and ecthyma gangrenosum as initial manifestations of primary immunodeficiency. Baro, María; Angel Marín, Miguel; Ruiz-Contreras, Jesús; Fernandez de Miguel, Sira; Sánchez-Díaz, Ignacio; Baro, María; Marín, Miguel Angel; Ruiz-Contreras, Jesús; de Miguel, Sira Fernandez; Sánchez-Díaz, Ignacio // European Journal of Pediatrics;2004, Vol. 163 Issue 3, p173 

    Reports on how Pseudomonas aeruginosa sepsis and ecthyma gangrenosum can be the initial manifestations of a primary immunodeficiency. Presentation of two cases of infants with such symptoms; Conclusion of most cases of Pseudomonas aeruginosa sepsis as nosocomially acquired and occur in subjects...

  • Pseudomonas aeruginosa bacteremia in patients with liver cirrhosis: a comparison with bacteremia caused by Enterobacteriaceae. Ji Hwan Bang; Younghee Jung; Shinhye Cheon; Chung Jong Kim; Kyung Ho Song; Pyeong Gyun Choe; Wan Beom Park; Eu Suk Kim; Sang Won Park; Hong Bin Kim; Myoung-don Oh; Hyo-Suk Lee; Nam Joong Kim // BMC Infectious Diseases;2013, Vol. 13 Issue 1, p1 

    Background: This study was performed to detect risk factors for Pseudomonas aeruginosa bacteremia in patients with liver cirrhosis. Methods: A retrospective case-control study was designed to identify risk factors for P. aeruginosa bacteremia in cirrhotic patients. The cases were cirrhotic...

  • Editorial Commentary: Combination Therapy for Pseudomonas aeruginosa Bacteremia: Where Do We Stand? Paul, Mical; Leibovici, Leonard // Clinical Infectious Diseases;Jul2013, Vol. 57 Issue 2, p217 

    The author reflects on the combination therapy for the treatment of Pseudomonas aeruginosa bacteremia. He states that the combination therapy increases the probability of an empirical coverage and improves the activity of antibiotics through synergism. He mentions that the effectiveness of the...

  • Colistin.  // Reactions Weekly;7/1/2006, Issue 1108, p7 

    The article presents a case report of several cancer patients who suffered from bacteremia caused by colistin-resistant Gram-negative bacilli after being exposed to ciprofloxacin and colistin. The patients were admitted to an intensive care unit with postoperative peritonitis. In one of the...

  • Tobramycin.  // Reactions Weekly;12/1/2007, Issue 1180, p37 

    The article describes the case of a 20-year-old woman who developed a liver injury associated with tobramycin therapy for Pseudomonas aeruginosa bacteraemia and osteomyelitis. The patient received empirical IV antibacterial therapy with piperacillin/tazobactam, ciprofloxacin and vancomycin for...

  • The importance of pharmacokinetic consultation of cefepime treatment for Pseudomonas aeruginosa bacteremia: a case report of severe thermal burn injury. Aoki, Yosuke; Urakami, Toshiharu; Magarifuchi, Hiroki; Nagasawa, Zenzo; Nagata, Masaki; Fukuoka, Mami // Journal of Infection & Chemotherapy (Springer Science & Business;Jun2011, Vol. 17 Issue 3, p407 

    The patient is a 54-year-old man with severe thermal burn injury involving 45.5% of the total body-surface area, complicated with bacteremia caused by Pseudomonas aeruginosa with a cefepime MIC of 8 µg/ml. The plasma concentrations of cefepime 1 g every 6 h measured by validated high...

  • Outcomes of Bacteremia due to Pseudomonas aeruginosa with Reduced Susceptibility to Piperacillin-Tazobactam: Implications on the Appropriateness of the Resistance Breakpoint. Tam, Vincent H.; Gamez, Eric A.; Weston, Jaye S.; Gerard, Laura N.; LaRocco, Mark T.; Caeiro, Juan Pablo; Gentry, Layne O.; Garey, Kevin W. // Clinical Infectious Diseases;3/15/2008, Vol. 46 Issue 6, p862 

    Background. Bacteremia due to Pseudomonas aeruginosa is associated with grave clinical outcomes. Recent studies have emphasized the importance of appropriate empirical therapy, but controversy arises when piperacillin-tazobactam is used against isolates with reduced susceptibility. Methods. We...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics